Jolanta Bialkowska
Lodz, LD, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Effectiveness of pangenotypic retreatment of chronic hepatitis C after prior failure of pangenotypic therapies.
Journal: Polish archives of internal medicine
Published: January 05, 2023
Hepatitis C Infection as a Risk Factor for Hypertension and Cardiovascular Diseases: An EpiTer Multicenter Study.
Journal: Journal of clinical medicine
Published: July 23, 2022
HCV Genotype Has No Influence on the Incidence of Diabetes-EpiTer Multicentre Study.
Journal: Journal of clinical medicine
Published: December 09, 2021
Five-Year Follow-Up of Cured HCV Patients under Real-World Interferon-Free Therapy.
Journal: Cancers
Published: June 17, 2021
Low risk of HBV reactivation in a large European cohort of HCV/HBV coinfected patients treated with DAA.
Journal: Expert review of anti-infective therapy
Published: June 16, 2020
Changes in patient profile, treatment effectiveness, and safety during 4 years of access to interferon-free therapy for hepatitis C virus infection.
Journal: Polish archives of internal medicine
Published: February 08, 2020
Sofosbuvir/velpatasvir in treatment-experienced HCV-infected patients - short report.
Journal: Clinical and experimental hepatology
Published: January 03, 2020
Comparative effectiveness of 8 versus 12 weeks of Ombitasvir/Paritaprevir/ritonavir and Dasabuvir in treatment-naïve patients infected with HCV genotype 1b with non-advanced hepatic fibrosis.
Journal: Advances in medical sciences
Published: February 09, 2019
Effect of comedication on ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin therapy in chronic hepatitis C - a real-world study.
Journal: Clinical and experimental hepatology
Published: January 21, 2019
Durability of virologic response, risk of de novo hepatocellular carcinoma, liver function and stiffness 2 years after treatment with ombitasvir/paritaprevir/ritonavir±dasabuvir±ribavirin in the AMBER, real-world experience study.
Journal: Journal of viral hepatitis
Published: March 06, 2018
Is Interferon-Based Treatment of Viral Hepatitis C Genotype 3 Infection Still of Value in the Era of Direct-Acting Antivirals?
Journal: Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research
Published: February 15, 2018
Cardiovascular risk assessment by electrocardiographic Holter monitoring in patients with chronic hepatitis C.
Journal: Archives of medical science : AMS
Published: February 07, 2018
Last Updated: 09/26/2026